Antithrombin III deficiency
Citation, DOI, disclosures and article data
At the time the article was created Yuranga Weerakkody had no recorded disclosures.View Yuranga Weerakkody's current disclosures
At the time the article was last revised Yaïr Glick had no recorded disclosures.View Yaïr Glick's current disclosures
Antithrombin (AT) III deficiency (now simply called antithrombin deficiency) refers to a congenital lack of the endogenous anticoagulant antithrombin.
Antithrombin deficiency is considered the least common of the three main anticoagulant deficiencies (the other two being protein C deficiency and protein S deficiency). Its incidence is thought to be ~1:2000-5000 1.
Antithrombin is a vitamin K-independent glycoprotein in the coagulation pathway. It is a major inhibitor of thrombin and other coagulation serine proteases, including factors Xa and IXa. The deficiency of antithrombin leads to a procoagulant state which is associated with an increased risk of thrombotic and embolic situations such as:
Radiology mainly plays a role in identifying thrombotic and embolic complications (see above). It is useful for the radiologist to be aware of the thrombotic risk associated with this deficiency.
Treatment and prognosis
Some publications favor the introduction of long-term oral anticoagulation treatment after the first thrombotic event 4.